Literature DB >> 7037149

Malignant interstitial cell tumor of the testis.

K T Chen, R W Spaulding, M S Flam, G M Brittin.   

Abstract

A case of malignant interstitial cell tumor of the testis is reported and the literature is reviewed. Malignant interstitial cell tumors occur exclusively in adults. Gynecomastia was noted in 12% of the cases. Elevated plasma levels or increased urinary excretion of estrogen, 17-ketosteroid, or testosterone were demonstrated in 64% of the patients. Vessel invasion, which occurred in 74% of the patients, appears to be the only reliable histologic feature for predicting malignant behavior. There is no proved sensitivity to radiation or chemotherapeutic regimens in patients with disseminated tumor. Once the diagnosis of malignancy is histologically established, inguinal and retroperitoneal lymph node dissections, even in the absence of clinical evidence of metastasis, may be beneficial in providing early staging of the tumor and, perhaps, in preventing subsequent lymphatic spread.

Entities:  

Mesh:

Year:  1982        PMID: 7037149     DOI: 10.1002/1097-0142(19820201)49:3<547::aid-cncr2820490325>3.0.co;2-2

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  A malignant Leydig cell tumor of the testis.

Authors:  Koichi Sugimoto; Seiji Matsumoto; Kazuhiro Nose; Takashi Kurita; Hirotsugu Uemura; Young-Chol Park; June Hanai
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

Review 2.  Malignant Leydig cell tumour of the testis: a case report and review of the literature.

Authors:  E Unlüer; D Ozcan; S Altin
Journal:  Int Urol Nephrol       Date:  1990       Impact factor: 2.370

Review 3.  Therapeutic strategies for uncommon testis cancer histologies: teratoma with malignant transformation and malignant testicular sex cord stromal tumors.

Authors:  Mounsif Azizi; Ahmet M Aydin; Salim K Cheriyan; Charles C Peyton; Matthew Montanarella; Scott M Gilbert; Wade J Sexton
Journal:  Transl Androl Urol       Date:  2020-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.